Inserm U1190

Excited to share our latest study with @stefano_romeo76 , published in @NatureMedicine! We uncover 2 distinct subtypes of MASH: 🔹 Liver-specific: Faster liver disease progression, lower CV risk. 🔹 Cardiometabolic: Higher CV/metabolic risks, incl. T2D. #citeas" target="_blank" rel="nofollow noopener">nature.com/articles/s4159…

New findings from U1190 team @CHU_Lille @univ_lille

Partitioning clustering based on clinical variables applied to multiple patients cohorts identifies two subtypes of #MASLD with different associations to #hepatic and #cardiovascular outcomes @francois_pattou @LilleInfinite nature.com/articles/s4159…

Congratulations to Pr. François Pattou and Dr. Violeta Raverdy for this collaborative study with Pr. Stefano Romeo published in @NatureMedicine : nature.com/articles/s4159… 👏🏻👏🏻👏🏻

Retrouvez l’histoire de Dominique, une de nos patientes greffées d’îlots il y a 11 ans au CHU de Lille : linkedin.com/posts/francois…

Retrouvez l’interview France Culture de notre Pr. Marie-Christine Vantyghem sur le diabète de type 1 et la greffe d’îlots : radiofrance.fr/franceculture/…

Our recent #Diabetes publication shows reducing intestinal SGLT1 expression lowers early glucose levels post-meal, suggesting a new way to manage T2D. diabetesjournals.org/diabetes/artic…

🚀Félicitations à @PreciDIABCenter pour le label " Équipe FRM 2023 " sur leur projet de médecine de précision en chirurgie métabolique ! Hier, la #RTD a eu l'honneur de recevoir Thierry Lhermitte, parrain de la @FRM_officiel. 👉precidiab.org/a-propos/notre… 📸Photos de #PreciDiab.

Very proud of our colleague @MaanaouiMehdi, who defended today his PhD like a champ on islet transplantation in diabetic patients with renal failure. A great article in prospect that will be much talked about! #welcomeinthePhDfamily #mbappeduglomerule @InsermU1190

Unmissable Opportunity #EPITAsymposium Don't miss out on the chance to present your research! The abstract submission deadline is set for 23 November at 23:59 CET, and 𝘁𝗵𝗲𝗿𝗲 𝘄𝗼𝗻'𝘁 𝗯𝗲 𝗮𝗻𝘆 𝗲𝘅𝘁𝗲𝗻𝘀𝗶𝗼𝗻𝘀. Be part of something great! go.esot.org/epitasymposium…

For those who asked us to see Felix Gretarsson @hrFelix intervention during EUROPEAN SOCIETY FOR SURGICAL RESEARCH @EssrMedia congress, please follow him on #YouTube here lnkd.in/e758DwkT Outstanding man, husband, father & speaker

Check out the last article from the lab @InsermU1190 @CHU_Lille @univ_lille @mikachet @francois_pattou 😁 Cognitive Outcome After Islet Transplantation : Transplantation Direct journals.lww.com/transplantatio…

✌ We're thrilled to share our newest article, just published online 👉 authors.elsevier.com/c/1gzcb7tNucn7… #research #science #diabetes #transplantation @UFR3S_ULille @CHU_Lille @univ_lille

So pleased and proud to share the last article in @TheLancetEndo from @InsermU1190 @francois_pattou lab: islet transplantation and primary graft function 👉 collaborative work with the CITR registry, led by the one and only @mikachet 🔥 authors.elsevier.com/c/1gzcb7tNucn7…

Inspiring @InsermU1190 @CHU_Lille @univ_lille

📢 A l'occasion de la #JournéeMondialedelObesite, le journal @Lille_actu fait le point avec le Pr @francois_pattou sur l'#obésité dans la région des @hautsdefrance et l'interroge sur les #traitements pour lutter contre l'obésité? 👇 @CHU_Lille actu.fr/hauts-de-franc…

BREAKING: The U.S. Food and Drug Administration (FDA) authorized the @tidepool_org Loop, an automated insulin dosing app intended for the management of type 1 diabetes (T1D). (1/3)

The KA IAK study. An outstanding presentation from our bro ⁦@MaanaouiMehdi⁩ ⁦@InsermU1190⁩ #trepid

The role of social media in transplantation masterfully 👏 presented by @Aimen_Amer & @MaanaouiMehdi #ESOT_EPITA #TransplantTwitter

And our first gentleman ⁦@MaanaouiMehdi⁩ ⁦@InsermU1190⁩ ⁦@francois_pattou⁩